All companies › DOCS

DOCS · Doximity, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells2
Research cases0
Last filing2026-10-01

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-30 — Yang Watkin Phoebe L. · sold 1,290 @ $26.71 2026-10-01 — Wampler Kira Scherer · sold 2,000 @ $28.91
2026-09-302026-10-01

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Yang Watkin Phoebe L. Director
Wampler Kira Scherer Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $DOCS is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-01', 'insider_name': 'Wampler Kira Scherer', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 2000.0, 'price': 28.91, 'value': 57820.0, 'is_buy': False}, {'transaction_date': '2026-09-30', 'insider_name': 'Yang Watkin Phoebe L.', 'insider_title': 'Director', 'transaction_type': 'Open-market sell', 'shares': 1290.0, 'price': 26.71, 'value': 34455.9, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for DOCS today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.